A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease
This study is testing an electronic tool called eMPOWER Decision Aid. This tool is built into electronic health records and uses your clinical information to help doctors decide the best way to manage your steatotic liver disease (MASLD). We want to see if using this tool helps more high-risk patients with MASLD get connected to liver specialists (hepatology care). You might be able to join if you are an adult (18 or older) with MASLD or liver fat seen on imaging, plus other risk factors like heart problems or long-term elevated liver enzymes. The study is currently unclear on its recruitment status.
- Study design
- This is a randomized study involving 7200 participants, where you would be assigned by chance to either receive care with the eMPOWER Decision Aid or usual care.
- What's involved
- You would have an outpatient clinic visit (in-person or telemedicine) at a participating clinic site, and your care would be followed for 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after starting the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease
At a glance
Conditions
NCT07382349
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Vanderbilt University Medical Center
Nashville, Tennesseeno site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Ashley Spann, MD, MSACI · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- The primary objective of this pragmatic trial is to assess the efficacy of the electronic decision support aid for increasing linkage to hepatology care for high-risk participants with MASLDBaseline to 12 months
Number of participants with new referrals placed to Hepatology for evaluation of high-risk status